Glaxosmithkline Plc Adr Stock Market Value
| GSK Stock | USD 34.33 0.31 0.91% |
| Symbol | GlaxoSmithKline |
GlaxoSmithKline PLC ADR Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.28) | Dividend Share 0.61 | Earnings Share 1.53 | Revenue Per Share 15.38 | Quarterly Revenue Growth (0.02) |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GlaxoSmithKline PLC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GlaxoSmithKline PLC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GlaxoSmithKline PLC.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in GlaxoSmithKline PLC on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding GlaxoSmithKline PLC ADR or generate 0.0% return on investment in GlaxoSmithKline PLC over 30 days. GlaxoSmithKline PLC is related to or competes with Novartis, AstraZeneca PLC, Roche Holding, Bristol Myers, Amgen, Merck, and AbbVie. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of ... More
GlaxoSmithKline PLC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GlaxoSmithKline PLC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GlaxoSmithKline PLC ADR upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.33) | |||
| Maximum Drawdown | 8.87 | |||
| Value At Risk | (2.56) | |||
| Potential Upside | 1.27 |
GlaxoSmithKline PLC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GlaxoSmithKline PLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GlaxoSmithKline PLC's standard deviation. In reality, there are many statistical measures that can use GlaxoSmithKline PLC historical prices to predict the future GlaxoSmithKline PLC's volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.58) | |||
| Treynor Ratio | (1.30) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
GlaxoSmithKline PLC ADR Backtested Returns
GlaxoSmithKline PLC ADR holds Efficiency (Sharpe) Ratio of -0.24, which attests that the entity had a -0.24% return per unit of standard deviation over the last 3 months. GlaxoSmithKline PLC ADR exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GlaxoSmithKline PLC's risk adjusted performance of (0.18), and Market Risk Adjusted Performance of (1.29) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.28, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GlaxoSmithKline PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding GlaxoSmithKline PLC is expected to be smaller as well. At this point, GlaxoSmithKline PLC ADR has a negative expected return of -0.36%. Please make sure to check out GlaxoSmithKline PLC's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if GlaxoSmithKline PLC ADR performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.07 |
Very weak reverse predictability
GlaxoSmithKline PLC ADR has very weak reverse predictability. Overlapping area represents the amount of predictability between GlaxoSmithKline PLC time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GlaxoSmithKline PLC ADR price movement. The serial correlation of -0.07 indicates that barely 7.0% of current GlaxoSmithKline PLC price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
GlaxoSmithKline PLC ADR lagged returns against current returns
Autocorrelation, which is GlaxoSmithKline PLC stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GlaxoSmithKline PLC's stock expected returns. We can calculate the autocorrelation of GlaxoSmithKline PLC returns to help us make a trade decision. For example, suppose you find that GlaxoSmithKline PLC has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GlaxoSmithKline PLC regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GlaxoSmithKline PLC stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GlaxoSmithKline PLC stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GlaxoSmithKline PLC stock over time.
Current vs Lagged Prices |
| Timeline |
GlaxoSmithKline PLC Lagged Returns
When evaluating GlaxoSmithKline PLC's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GlaxoSmithKline PLC stock have on its future price. GlaxoSmithKline PLC autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GlaxoSmithKline PLC autocorrelation shows the relationship between GlaxoSmithKline PLC stock current value and its past values and can show if there is a momentum factor associated with investing in GlaxoSmithKline PLC ADR.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out GlaxoSmithKline PLC Correlation, GlaxoSmithKline PLC Volatility and GlaxoSmithKline PLC Alpha and Beta module to complement your research on GlaxoSmithKline PLC. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.